Treatment of cancer with drugs: A controversy

Annals of Oncology

Volumn 22, Issue 3, 2011, Pages 747-748

  Guedea, F ^a   Macia M ^a   Sanchez Calzado, J A ^b   Ramos, A ^c   Lopez Torrecilla, J L ^d   Herruzo, I ^e   Contreras, J ^e   Romero, J ^f   Willisch, P ^g  

^a CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^c HOSPITAL RAMÓN Y CAJAL   (Spain)

^d HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^e HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^f HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^g HOSPITAL DO MEIXOEIRO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER RADIOTHERAPY; CLINICAL COMPETENCE; CLINICAL PRACTICE; DRUG EFFICACY; DRUG SAFETY; HEALTH CARE; HEALTH CARE QUALITY; HUMAN; LETTER; MEDICAL SPECIALIST; NEOPLASM; PATIENT CARE; PATIENT SAFETY; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; SPAIN; WELLBEING;

COMBINED MODALITY THERAPY; DELIVERY OF HEALTH CARE; HUMANS; INTERDISCIPLINARY COMMUNICATION; NEOPLASMS; PATIENT-CENTERED CARE; SPAIN; TERMINOLOGY AS TOPIC;

EID: 79952029774     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdq760     Document Type: Letter

References (7)

1. Colomer R, Alba E, Gonzalez-Martin A et al. Treatment of cancer with oral drugs: a position statement by the Spanish Society of Medical Oncology. Ann Oncol 2010; 21: 195-198.
2. Orden SCO/3142/2006, de 20 de septiembre, por la que se aprueba y publica el programa formativo de la especialidad de Oncología Radioterá pica. BOE 245 del Viernes 13 Octubre 2006, 35519-35527.
3. Zietman A. The future of radiation oncology: the evolution, diversification and survival of the specialty. Sem Radiat Oncol 2008; 18(3): 207-213.
4. SBU. The Swedish council on technology assessment in health care. Radiotherapy for cancer. Volume 1. Acta Oncol 1996; 35 (Suppl 6): 47-49.
5. Hansen HH, Bajorin DF, Muss HB et al. Recommendations for a global core curriculum in medical oncology. Ann Oncol 2004; 15: 1603-1612.
6. Meropol NJ, Schrag D, Smith TJ et al. American Society of Clinical Oncology guidance statement: the cost of cancer care. J Clin Oncol 2009; 27(23): 3868-3874.
7. Maciá M. Rebelarse, Someterse o Pactar. SEOR Actúa 2007, Boletín n 2.